The US government has resumed its pressure on Argentina, with US Ambassador James Cheek claiming that the country's new patent bill offers no guarantees for investments, reports South American Business News.
He said that Brazil's new patent law, which takes effect from next year, will attract pharmaceutical investments there, but Argentina's will not.
The Argentine national drug industry association, Cilfa, has replied that during 1994-96, $800 million-worth of investment was made in the domestic drug industry, of which $400 million came from overseas companies and $350 million was made by local firms.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze